Kemnay Advisory Services’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
FLSM
JT
Kemnay Advisory Services's MIRM Position: Q2 2026 in Review
Kemnay Advisory Services increased its Mirum Pharmaceuticals (MIRM) stake by 2.8% in Q2 2026, buying an estimated $1.3K and bringing the position to 476 shares worth $55.7K. The position accounts for 0.01% of the portfolio, ranked #264.
Kemnay Advisory Services first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.
- Kemnay Advisory Services held 476 shares of Mirum Pharmaceuticals worth $55.7K as of Q2 2026.
- Kemnay Advisory Services bought 13 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.3K.
- Mirum Pharmaceuticals made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #264 holding.
- Kemnay Advisory Services first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.